MACSF
Investor profile
MACSF has backed 5 European tech companies across 6 funding rounds between 2020 and 2023, joining rounds totalling €143M. Most active in Healthtech and Robotics. Data as of 4 Nov 2026.
Deals
6
distinct rounds
Companies
5
backed
Active span
2020–2023
4 yrs
Total round €
€143M
sum of rounds joined
Deals by year
distinct rounds / yearMACSF — deals by year — interactive chart.
Data table
| MACSF — deals by year | |
|---|---|
| 2020 | 1 |
| 2022 | 3 |
| 2023 | 2 |
Top sectors
by dealsMACSF — top sectors — interactive chart.
Data table
| MACSF — top sectors | |
|---|---|
| Healthtech | 5 |
| Robotics | 1 |
Stages
by dealsMACSF — stages — interactive chart.
Data table
| MACSF — stages | |
|---|---|
| Other | 3 |
| Series B | 2 |
| Series C | 1 |
Countries
by dealsMACSF — countries — interactive chart.
Data table
| MACSF — countries | |
|---|---|
| France | 6 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- XAnge3
- Bpifrance2
- AG2R La Mondiale1
- BNP Paribas Development1
- Capital Grand Est1
- Cathay Innovation1
- Cemag Invest1
- Crista Galli Ventures1
- Elaia Partners1
- Exor Seeds1
- Fleur Pellerin investment fund1
- Fondation Santé Service1
- Heal Capital1
- IDInvest Partners1
- Korelya Capital1
- LBO France1
- Malakoff Humanis1
- Mutuelles Impact1
- Picus Capital1
- Quadrant Management1
- Ramsay Santé1
- Seaya Ventures1
- Singular1
- Sofiouest1
- Supernova Invest1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Resilience | France | 1 | €40M |
| Wandercraft | France | 1 | €40M |
| Synapse Medicine | France | 2 | €32M |
| Gleamer | France | 1 | €27M |
| BrainTale | France | 1 | €4.5M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Resilience | Other | €40M | 2022-01 |
| Wandercraft | Series C | €40M | 2022-01 |
| Gleamer | Series B | €27M | 2023-06 |
| Synapse Medicine | Series B | €25M | 2022-03 |
| Synapse Medicine | Other | €7.1M | 2020-07 |
| BrainTale | Other | €4.5M | 2023-06 |